Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 2.9B | 2.3B | 2.7B | 2.8B |
Cost of revenue | 1.5B | 1.2B | 1.4B | 1.4B |
Gross profit | 1.4B | 1.2B | 1.3B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 501.5M | 440.9M | -482.8M | 525.2M |
Other operating expenses | 16.7M | 25.6M | 988.4M | 15.1M |
Operating income | 291.9M | 145M | 289.1M | 329.3M |
Non operating interest income | ||||
Income | 300K | 1.7M | 200K | 300K |
Expense | 78.7M | 88.4M | 111.7M | 113M |
Other income expense | — | — | — | — |
Pretax income | 158.6M | 78.1M | 545.2M | 201.9M |
Tax provision | 79.3M | -15.1M | -14.6M | 43.5M |
Net income | 79.3M | 93.2M | 559.8M | 158.4M |
Basic EPS | 1.1 | 1.3 | — | 2.3 |
Diluted EPS | 1.1 | 1.3 | — | 2.3 |
Basic average shares | 74.3M | 71.4M | — | 68.9M |
Diluted average shares | 74.3M | 71.4M | — | 68.9M |
EBITDA | 443.3M | 325.9M | 462.7M | 463.1M |
Net income from continuing op. | 158.6M | 78.1M | 545.2M | 201.9M |
Minority interests | -800K | 2.2M | -90.3M | -3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |